Pro-apoptotic properties of (1,3)(1,4)-β-d-glucan from Avena sativa on human melanoma HTB-140 cells in vitro

International Journal of Biological Macromolecules

Volumn 72, Issue , 2015, Pages 757-763

  Parzonko, Andrzej ^a   Makarewicz Wujec, Magdalena ^a   Jaszewska, Edyta ^a   Harasym, Joanna ^b   Kozłowska Wojciechowska, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b WROCLAW UNIVERSITY OF ECONOMICS   (Poland)

Author keywords

(1,3)(1,4) d Glucan; Apoptosis; Avena sativa

Indexed keywords

(1,3) (1,4) BETA DEXTRO GLUCAN; ADENOSINE TRIPHOSPHATE; CASPASE 3; CASPASE 7; LACTATE DEHYDROGENASE; PHOSPHATIDYLSERINE; PLANT EXTRACT; POLYSACCHARIDE; UNCLASSIFIED DRUG; BETA GLUCAN; BETA-GLUCAN, (1-3)(1-4)-;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MEMBRANE; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOLECULAR WEIGHT; OAT; OAT BRAN; CHEMISTRY; DRUG EFFECTS; MELANOMA; PATHOLOGY; TUMOR CELL LINE;

AVENA SATIVA;

APOPTOSIS; AVENA SATIVA; BETA-GLUCANS; CELL CYCLE; CELL LINE, TUMOR; HUMANS; MELANOMA; PLANT EXTRACTS;

EID: 84907961886     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.09.033     Document Type: Article

References (24)

1. Dalmo R.A., Bøgwald J. Fish Shellfish Immunol. 2008, 25:384-396.
2. Liu J., Gunn L., Hansen R., Yan J. Exp. Mol. Pathol. 2009, 86:208-214.
3. Novak M., Vetvicka V. J. Immunotoxicol. 2008, 5:47-57.
4. Wang Y., Zhang L., Li Y., Hou X., Zeng F. Carbohydr. Res. 2004, 20:2567-2574.
5. Fullerton S.A., Samadi A.A., Tortorelis D.G., Choudhury M.S., Mallouh C., Tazaki H., Konno S. Mol. Urol. 2000, 4:7-13.
6. Zhang M., Chiu L.C., Cheung P.C., Ooi V.E. Oncol. Rep. 2006, 15:637-643.
7. Jiménez-Medina E., Berruguilla E., Romero I., Algarra I., Collado A., Garrido F., Garcia-Lora A. BMC Cancer 2008, 8:78-88.
8. Yoon T.J., Koppula S., Lee K.H. Anticancer Agents Med. Chem. 2013, 13:699-708.
9. Mantovani M.S., Bellini M.F., Angeli J.P., Oliveira R.J., Silva A.F., Ribeiro L.R. Mutat. Res. 2008, 658:154-161.
10. Chen J., Seviour R. Mycol. Res. 2007, 111:635-652.
11. Wasser S.P. Appl. Microbiol. Biotechnol. 2002, 60:258-274.
12. Cheung N.K., Modak Oral S. Cancer Res. 2002, 8:1217-1223.
13. Hong F., Yan J., Baran J.T., Allendorf D.J., Hansen R.D., Ostroff G.R., Xing P.X., Cheung N.-K.V., Ross G.D. Immunology 2004, 173:797-806.
14. Modak S., Koehne G., Vickers A., O'Reilly R.J., Cheung N.K. Leuk. Res. 2005, 29:679-683.
15. Cheung N.K., Modak S., Vickers A., Knuckles B. Cancer Immunol. Immunother. 2002, 51:557-564.
16. Rondanelli M., Opizzi A., Monteferrario F. Minerva Med. 2009, 100:237-245.
17. Sikora P., Tosh S.M., Brummer Y., Olsson O. Food Chem. 2013, 137:83-91.
18. Sadiq Butt M., Tahir-Nadeem M., Khan M.K., Shabir R., Butt M.S. Eur. J. Nutr. 2008, 47:68-79.
19. Estrada A., Yun C.H., Van Kessel A., Li B., Hauta S., Laarveld B. Microbiol. Immunol. 1997, 41:991-998.
20. Murphy E.A., Davis J.M., Brown A.S., Carmichael M.D., Mayer E.P., Ghaffar A. J. Appl. Physiol. 2004, 97:955-959.
21. Harasym J., Brac H., Czarnota J.L., Stechman M., Słabisz A., Kowalska A., Chorowski M., Winkowski M., Rać J., Madera A. A Kit and a Method of Producing Beta-glucan Insoluble Food Fibre as well as a Preparation of Oat Proteins 2012, Wroclaw Technology Park, Wroclaw.
22. Gogvadze V. Curr. Pharm. Des. 2011, 36:4034-4046.
23. Hirahara N., Edamatsu T., Fujieda A., Fujioka M., Wada T., Tajima Y. Anticancer Res. 2012, 32:2631-2637.
24. Akramiene D., Aleksandraviciene C., Grazeliene G., Zalinkevicius R., Suziedelis K., Didziapetriene J., Simonsen U., Stankevicius E., Kevelaitis E. Tohoku J. Exp. Med. 2010, 220:299-306.